204 related articles for article (PubMed ID: 34139660)
1. Probing the association between Multiple Sclerosis and Epstein Barr Virus from a therapeutic perspective.
Drosu N; Giovannoni G; Pohl D; Hawkes C; Lechner-Scott J; Levy M
Mult Scler Relat Disord; 2021 Jul; 52():103087. PubMed ID: 34139660
[No Abstract] [Full Text] [Related]
2. Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: no.
Salzer J; Myhr KM
Mult Scler; 2013 Nov; 19(13):1692-3. PubMed ID: 24218487
[No Abstract] [Full Text] [Related]
3. Epstein-Barr virus and multiple sclerosis.
Lovett-Racke AE; Racke MK
Arch Neurol; 2006 Jun; 63(6):810-1. PubMed ID: 16769860
[No Abstract] [Full Text] [Related]
4. EBV and multiple sclerosis: Setting the research agenda.
Giovannoni G; Vanderdonckt P; Hartung HP; Lassmann H; Comi G
Mult Scler Relat Disord; 2022 Nov; 67():104158. PubMed ID: 36116382
[No Abstract] [Full Text] [Related]
5. Epstein-Barr Virus and Multiple Sclerosis: New Light on an Old Idea BjornevikKCorteseMHealyBCKuhleJMinaMJLengY, and others. 2022. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science375(6578):296-301. LanzTVBrewerRCHoPPMoonJSJudeKMFernandezD, and others. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature2022;603:321-7.
Neuroscientist; 2022 Apr; 28(2):97. PubMed ID: 35441540
[No Abstract] [Full Text] [Related]
6. Impact of genetic variation on the molecular mimicry between Anoctamin-2 and Epstein-Barr virus nuclear antigen 1 in Multiple Sclerosis.
Sepúlveda N
Immunol Lett; 2021 Oct; 238():29-31. PubMed ID: 34310987
[No Abstract] [Full Text] [Related]
7. Epstein-barr virus: environmental trigger of multiple sclerosis?
Lünemann JD; Kamradt T; Martin R; Münz C
J Virol; 2007 Jul; 81(13):6777-84. PubMed ID: 17459939
[No Abstract] [Full Text] [Related]
8. Fine specificity of the antibody response to Epstein-Barr nuclear antigen-2 and other Epstein-Barr virus proteins in patients with clinically isolated syndrome: A peptide microarray-based case-control study.
Schlemm L; Giess RM; Rasche L; Pfuhl C; Wakonig K; Behrens JR; Scheibenbogen C; Bellmann-Strobl J; Paul F; Reimer U; Ruprecht K
J Neuroimmunol; 2016 Aug; 297():56-62. PubMed ID: 27397076
[TBL] [Abstract][Full Text] [Related]
9. [Infection by Epstein-Barr virus and multiple sclerosis].
Alonso A; Egüés Olazábal N; Ayo Martín O
Neurologia; 2006 Jun; 21(5):249-55. PubMed ID: 16788867
[TBL] [Abstract][Full Text] [Related]
10. Is EBV the cause of multiple sclerosis?
Giovannoni G; Hawkes CH; Lechner-Scott J; Levy M; Yeh EA; Gold J
Mult Scler Relat Disord; 2022 Feb; 58():103636. PubMed ID: 35114510
[No Abstract] [Full Text] [Related]
11. Epstein-Barr virus candidate genes and multiple sclerosis.
Claire Simon K; Schmidt H; Loud S; Ascherio A
Mult Scler Relat Disord; 2015 Jan; 4(1):60-4. PubMed ID: 25787055
[TBL] [Abstract][Full Text] [Related]
12. In the era of antiviral trials for MS, the answer lies in the details.
Drosu N; Bjornevik K; Bilodeau PA; Yeh A; Lechner-Scott J; Hawkes CH; Giovannoni G; Levy M
Mult Scler Relat Disord; 2024 Feb; 82():105444. PubMed ID: 38241758
[No Abstract] [Full Text] [Related]
13. Antiviral immune response in patients with multiple sclerosis, healthy siblings and twins.
Ristori G; Mechelli R; Anderson J; Mengoni F; Sauzullo I; Annibali V; Cannoni S; Aloisi F; James JA; Salvetti M
Mult Scler; 2010 Dec; 16(12):1527-8. PubMed ID: 20798134
[No Abstract] [Full Text] [Related]
14. Multiple sclerosis: the elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1.
Ruprecht K; Wunderlich B; Gieß R; Meyer P; Loebel M; Lenz K; Hofmann J; Rosche B; Wengert O; Paul F; Reimer U; Scheibenbogen C
J Neuroimmunol; 2014 Jul; 272(1-2):56-61. PubMed ID: 24798244
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D: a link between Epstein-Barr virus and multiple sclerosis development?
Disanto G; Meier U; Giovannoni G; Ramagopalan SV
Expert Rev Neurother; 2011 Sep; 11(9):1221-4. PubMed ID: 21864064
[No Abstract] [Full Text] [Related]
16. Is multiple sclerosis a glymphaticopathy?
Alghanimy AA; Giovannoni G; Lechner-Scott J; Levy M; Yeh EA; Hawkes CH
Mult Scler Relat Disord; 2023 Dec; 80():105141. PubMed ID: 38039696
[No Abstract] [Full Text] [Related]
17. Epstein-Barr virus antibody in newly diagnosed multiple sclerosis patients and its association with relapse severity and lesion location.
Olmez O; Baba C; Abasiyanik Z; Ozakbas S
Mult Scler Relat Disord; 2022 Dec; 68():104149. PubMed ID: 36096010
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus and multiple sclerosis: association or causation?
Pakpoor J; Giovannoni G; Ramagopalan SV
Expert Rev Neurother; 2013 Mar; 13(3):287-97. PubMed ID: 23448218
[TBL] [Abstract][Full Text] [Related]
19. Plasma viral load of Epstein-Barr virus and risk of multiple sclerosis.
Wagner HJ; Munger KL; Ascherio A
Eur J Neurol; 2004 Dec; 11(12):833-4. PubMed ID: 15667414
[TBL] [Abstract][Full Text] [Related]
20. Radioactive in situ hybridization for Epstein-Barr virus-encoded small RNA supports presence of Epstein-Barr virus in the multiple sclerosis brain.
Serafini B; Muzio L; Rosicarelli B; Aloisi F
Brain; 2013 Jul; 136(Pt 7):e233. PubMed ID: 23355688
[No Abstract] [Full Text] [Related]
[Next] [New Search]
